1,713 Shares in Cardinal Health, Inc. $CAH Purchased by River Street Advisors LLC

River Street Advisors LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, Holdings Channel reports. The institutional investor purchased 1,713 shares of the company’s stock, valued at approximately $288,000.

Several other large investors have also recently added to or reduced their stakes in the company. Hilltop National Bank purchased a new position in Cardinal Health during the second quarter worth about $236,000. Mirae Asset Global Investments Co. Ltd. grew its position in Cardinal Health by 2.1% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,803 shares of the company’s stock worth $5,511,000 after buying an additional 690 shares during the period. Riverview Trust Co grew its position in Cardinal Health by 16.9% during the second quarter. Riverview Trust Co now owns 1,037 shares of the company’s stock worth $174,000 after buying an additional 150 shares during the period. CHURCHILL MANAGEMENT Corp grew its position in Cardinal Health by 0.4% during the second quarter. CHURCHILL MANAGEMENT Corp now owns 242,896 shares of the company’s stock worth $40,807,000 after buying an additional 1,057 shares during the period. Finally, Pure Financial Advisors LLC grew its position in Cardinal Health by 34.9% during the second quarter. Pure Financial Advisors LLC now owns 2,406 shares of the company’s stock worth $404,000 after buying an additional 622 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jason M. Hollar sold 35,901 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the sale, the chief executive officer owned 200,000 shares in the company, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 in the last 90 days. Insiders own 0.12% of the company’s stock.

Wall Street Analysts Forecast Growth

CAH has been the topic of several recent analyst reports. Evercore ISI lowered their target price on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 13th. Leerink Partners lowered their target price on shares of Cardinal Health from $188.00 to $186.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 12th. UBS Group restated a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Argus set a $189.00 target price on shares of Cardinal Health in a research report on Friday, August 22nd. Finally, Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $165.93.

Cardinal Health Price Performance

CAH stock opened at $158.50 on Friday. The company’s 50 day simple moving average is $152.12 and its 200-day simple moving average is $150.09. The firm has a market capitalization of $37.66 billion, a PE ratio of 24.57, a P/E/G ratio of 1.34 and a beta of 0.71. Cardinal Health, Inc. has a 12 month low of $106.98 and a 12 month high of $168.44.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the prior year, the business earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.